European Lithium Ltd - Issue of Shares
RNS Number : 4563U
European Lithium Limited
29 March 2019
 

European Lithium Ltd

("European Lithium", "EUR" or "the Company")

Issue of Shares

European Lithium Limited (ASX:EUR, FRA:PF8, VSE:ELI, NEX:EUR) (the Company) advises that a total of 4,872,694 fully paid shares (the Shares) have been issued. The full announcement can be seen at: https://www.asx.com.au/asx/statistics/announcements.do?by=asxCode&asxCode=EUR&timeframe=D&period=M6

 

Of the 4,872,694 Shares, 3,872,694 shares are being issued as a result of a partial conversion of convertible notes issued to MEF I LP as announced on 7 September 2018. In addition, 1,00,000 shares are being issed as a result of exercise of options of $0.10 each from a separate holder.

 

Application has been made for the Shares to be admitted to trading on NEX ("Admission"). Admission is expected to occur at 8:00am on or around 4th April 2019. Following Admission, the Company's issued share capital will comprise 563,587,302 ordinary shares of no par value, with each share carrying the right to one vote. The Company does not hold any ordinary shares in treasury.  The above figure of 563,587,302 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or of a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

- END -

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014

Visit the Company's website to find out more about the advanced Wolfsberg Lithium Project located in Austria.

For further information please contact:

European Lithium Ltd

+61 861 819 792

Tony Sage

info@europeanlithium.com

 

 

NEX Corporate Adviser

+44 207 220 1666

James Joyce


James Sinclair-Ford




 


This information is provided by RNS, the news service of the . RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NEXGIGDXDGDBGCC ]]>